Journals
Books
Articles by keyword oncological disruption
Genetic predisposition in the formation of the risk of thromboembolism in cancer patients

M.L. Filipenko –

Ph.D. (Biol.), Head of Pharmacogenomics Laboratory, Institute of Chemical Biology and Fundamental Medicine,

Siberian Branch of the Russian Academy of Sciences (Novosibirsk)

E-mail: max@niboch.nsc.ru

O.V. Somonova –

Dr.Sc. (Med.), Professor, N.N. Blokhin National Medical Research Center of Oncology of the Ministry

of Health of Russia (Moscow)

A.L. Elizarova –

Ph.D. (Biol.), N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health

of Russia (Moscow)

N.E. Kushlinskii –

Dr.Sc. (Med.), Professor, Academician RAS, Head of the Laboratory of Clinical Biochemistry N.N. Blokhin

National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow)

Genetic predisposition in the formation of the risk of thromboembolism in cancer patients

M.L. Filipenko – 

Ph.D. (Biol.), Head of Pharmacogenomics Laboratory, Institute of Chemical Biology and Fundamental Medicine,

Siberian Branch of the Russian Academy of Sciences (Novosibirsk)

E-mail: max@niboch.nsc.ru

O.V. Somonova – 

Dr.Sc. (Med.), Professor, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow)

A.L. Elizarova – 

Ph.D. (Biol.), N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow)

N.E. Kushlinskii – 

Dr.Sc. (Med.), Professor, Academician RAS, Head of the Laboratory of Clinical Biochemistry N.N. Blokhin 

National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow)